Skip to main content
OpenTrials
Completed

NCT Number: NCT03013283

CPAP and NIV Interfaces : Side-effects in Home Care Patients

Home ventilation techniques consist mainly of two techniques, Continuous Positive Airway Pressure or CPAP and Non Invasive Ventilation or NIV. Whether for CPAP or NIV, pressures are delivered to the patient via an interface.

The efficacy of CPAP and NIV is conditioned in part by the observance of the patients to the device. Because the comfort and degree of satisfaction of the patients to its interface is a key factor of the observance, side-effects and satisfaction of patients need to be continuously evaluated with available interfaces for CPAP and NIV treated patients.

The purpose of the research is the evaluation of interface side-effects and the degree of satisfaction of home care patients treated for at least three months with CPAP or NIV.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Centre Hospitalier Universitaire de Montpellier, Montpellier, France

Loading trial locations.

About this study

Home ventilation techniques consist mainly of two techniques, Continuous Positive Airway Pressure or CPAP (the level of pressure delivered being constant) and Non Invasive Ventilation or NIV (pressure level varies from an expiratory pressure to an inspiratory pressure). Whether for CPAP or NIV, pressures are delivered to the patient via an interface. Many manufacturers produce interfaces and these interfaces are the subject of regular technological innovations with the introduction on the market of new product ranges.

Because of the lack of dedicated and actualized studies, there is poor evidence based of difference between old and new interfaces, there is also poor evidence based of differences between manufacturer products.

The efficacy of CPAP and NIV is conditioned in part by the observance of the patients to the device. Because the comfort and degree of satisfaction of the patients to its interface is a key factor of the observance, side-effects and satisfaction of patients need to be continuously evaluated with available interfaces for CPAP and NIV treated patients.

The purpose of the research is the evaluation of interface side-effects and the degree of satisfaction of home care patients treated for at least three months with CPAP or NIV. A visual analog scale is used to assess the patient perception of its interface. A measure of the quality of life and a home care technician evaluation are performed simultaneously. Using the device manufacturer software, a measure of the observance, level of pressure and leak is realised.

A first intermediate analysis will be made after approximately 1000 inclusions (the Sleepileaks (determinants of residual excessive sleapiness), Threshleaks (high leak levels and machine adherence as defined by the American Thoracic Society) and Complileaks studies (all leaks and machine adherence as continuous variables)). A second validating analysis will be made at the end of inclusions.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Written informed consent
  • Age more than 18 years (inclusive)
  • Patient treated with CPAP or NIV for at least three months,and eligible for care and for the reimbursement by the French Social Security rules.
  • Patient presents during a scheduled home visit of the technician for the continuation of CPAP or NIV treatment according to the French Social Security rules.

Exclusion criteria

  • Pregnancy, intention of being pregnant, breastfeeding.
  • Inability to understand the nature and aims of the study or to communicate with the investigator
  • Simultaneous participation in another trial with an exclusion clause to participate to an other trial.
  • No affiliation to the French social security
  • Loss of personal capacity resulting in state protection
  • Deprivation of liberty by judicial or administrative decision

Treatment and study plan

Self questionnaire

Other
  • Interface side effects and degree of satisfaction of the patients
  • Technician evaluation and device measures.

Primary outcomes

  1. Interface side effects and degree of satisfaction of the patients

    Time frame: 1 day

    During a scheduled home visit of the technician. The primary endpoint is a composite criterion corresponding to the patients' responses to a self-administered questionnaire.

Secondary outcomes

  1. Identification by the technician of the problems of pain

    Time frame: 1 day

    During a scheduled home visit of the technician : Identification by the technician of the problems of pain, erythema and leak, localization of these problems.

  2. Percentage of patients with oxygen therapy, heated humidifier, chinstrap.

    Time frame: 1 day

    During a scheduled home visit of the technician : Percentage of patients with oxygen therapy, heated humidifier, chinstrap.

  3. Collection by technician of the type of interface

    Time frame: 1 day

    During a scheduled home visit of the technician : Collection by technician of the type of interface (nasal pillows, nasal and oronasal, custom made interface), manufacturer name and interface size, type (CPAP/NIV) and manufacturer name of the device.

  4. Compliance

    Time frame: 1 day

    During a scheduled home visit of the technician : Device software data: compliance (hour per day) over the last 3 months

  5. Average level of intentional or unintentional leakage

    Time frame: 1 day

    During a scheduled home visit of the technician : Device software data: average level of intentional or unintentional leakage (l/min)

  6. Residual AHI

    Time frame: 1 day

    During a scheduled home visit of the technician : Device software data: residual AHI (event/hour)

  7. Average pressure level and pressure

    Time frame: 1 day

    During a scheduled home visit of the technician :Device software data: average pressure level and pressure at the 90/95th percentile (cmH2O).

  8. Patient quality of life questionnaire

    Time frame: 1 day

    Patient quality of life questionnaire (EQ-5D 3L, Epworth).

  9. Date of first installation of the first ventilation device

    Time frame: 1 day

    Date of first installation of the first ventilation device

  10. Proportion of patient responding to self-help questionnaire without assistance

    Time frame: 1 day

    Proportion of patient responding to self-help questionnaire without assistance

  11. Proportion of patients able to position the interface without assistance

    Time frame: 1 day

    Proportion of patients able to position the interface without assistance

  12. Time taken by the patient and the technician to answer the patient's self-questionnaire and the technician record respectively.

    Time frame: 1 day

    Time taken by the patient and the technician to answer the patient's self-questionnaire and the technician record respectively.

  13. Proportion of patient waiting for a new interface

    Time frame: 1 day

    Proportion of patient waiting for a new interface

  14. Proportion of patients wishing to participate in research on the subject.

    Time frame: 1 day

    Proportion of patients wishing to participate in research on the subject.

Sponsors and collaborators

Lead sponsor

University Hospital, Montpellier

Other

Registry information

Official study title

Descriptional Study of the Side Effects Related to the Use of the Interface in Home Care Patients Treated for at Least 3 Months by Continuous Positive Pressure or Non-Invasive Ventilation.

Acronym: InterfaceVent

Important dates

Study start
2017
Primary completion
2019
Study completion
2019
First posted
Jan 6, 2017
Registry last updated
Jan 27, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.